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We write as a tribute to Jim Neel, whose accomplish-
ments during his long and full life were a major factor
in the development of modern human genetics. Although
battling a string of formidable ailments, he was active
and typically feisty to the end. Shuffleboard in the sun
was not for him. It is more than a little ironic that the
first two pages of the new millennium in this Journal,
which he helped found, are devoted to his last paper
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(Neel 2000). As demonstrated by his other papers pub-
lished in 1999, even at 84 he was articulate, forthright,
and knowledgeable as ever.
Personal History (see Neel 1994)
James van Gundia Neel was born on March 22, 1915,
in Hamilton, Ohio. He graduated in 1935 from the Col-
lege of Wooster (Ohio), where, under Warren Spencer,
he investigated natural genetic variation in Drosophila.
This laid the foundation for the scientific inquiry in-
to the role of evolutionary forces—particularly muta-
tion—in the genetic complexities of natural populations,
which was to be the hallmark of his entire career. Jim
did his graduate work at the University of Rochester
(New York), pursuing genetic variability in Drosophila
under Curt Stern, who was also happy to indulge his
young student’s desire to learn about human genetics.
At that time, there was relatively little to know; but it
whetted Jim’s interest, and he would rapidly become one
of our foremost human geneticists.
In 1939, with a newly minted Ph.D., he accepted a
post at Dartmouth. There he discovered a Drosophila
strain in which variability in bristle number seemed to
be driven by a high mutation rate. This stimulated his
lifelong general interest in mutation as a potent evo-
lutionary force. However, with his leanings toward
human genetics in particular—and with war being im-
minent—Jim modified his career path by entering med-
ical school at Rochester and was inducted into the U.S.
Army. As a young clinician, he became conversant with
a number of heritable clinical issues, notably the hem-
oglobinopathies such as thalassemia. However, it had
been known since the turn of the century that most
diseases were not “genetic” in the usual sense of the
term, and, because human genetics had also been
stained by its recent role in eugenics, it was considered
a dubious field for an ambitious young physician to
enter (Neel 1994). But genes are key to human life, and
Jim—never one to shy from a challenge—became a hu-
man geneticist anyway.
Jim and Priscilla Baxter married in 1943 and suc-
cessfully raised three children, Frances, James, and Al-
exander. After residency in Rochester and a stint with
the Atomic Bomb Casualty Commission (ABCC) in Ja-
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pan, he assumed his lifelong post at the University of
Michigan. Jim had high professional standards and did
not seek personal attention, but he nonetheless quickly
attained scientific prominence and eventually became
the recipient of most of the important academic honors
that can be bestowed on a biomedical scientist: member
of the National Academy of Sciences since 1963 and
recipient of the Lasker and Allen Awards and of the
National Medal of Science. Over the years, he was called
on for considerable national and international advisory
service, although he had a remarkable ability to say no
to things that he did not deem important.
Professional Human Genetics: A Founder
It is a sign of the times that, as the century turned, all
too few readers of this journal might have recognized
the name of James V. Neel and its significance for our
Society and Journal. Like other founders, his achieve-
ments were being eclipsed by the explosive success of
contemporary human genetics. He was an instigator of
the 1947 meeting that led to the foundation of the So-
ciety in 1948, and his career was inextricably entwined
with the Society: board of directors (1948–50,
1968–70), vice-president (1952–57), and president
(1953–54). He wrote the first paper published in the
Journal (immediately following Herman Muller’s pref-
ace), and just this January he provided a firsthand review
of its history (Neel 2000).
Over his long career, Jim helped bring to prominence
many of the research activities that preoccupy our mem-
bers today. In founding the Department of Human Ge-
netics (DHG) at Michigan, one of the first in the country,
Jim bestowed a distinguished intellectual depth that gen-
erally set rather than followed scientific fashion. Tech-
nology and topicality were important, but always in
service to broader questions. Rather than constrain the
DHG’s focus to rare Mendelian disease (Neel 1950),
Jim took a broader, population view, querying whether
we had “forgotten to set up the team which has as its
concern the species as a whole?” (Neel 1958a; 1994, p.
32). To this end he recruited an impressive diversity of
scientists to the DHG, who had skills ranging from
phage genetics through statistical genetics to somatic-
cell genetics. It was noteworthy that a strong sense of
evolution permeated the DHG, relatively unusual in
those days and perhaps even more so today. Jim’s pre-
occupation with evolutionary processes may have
stemmed from his premedical training, but it found a
receptive audience in the staff and students in the DHG
and formed the keystone of most of the major studies
that came from the DHG. In our technology-driven
times, in which students are rapidly specialized, a med-
ical school department with a preoccupation with ev-
olution may seem quaint. But nature will out: the dif-
ficulty of making sense of the flood of sequence data
that now confronts us is a salutary reminder that ad-
herence to the basic biological processes that generate
that variation is essential—as Jim would have told us,
had we asked.
The DHG has been home to many prominent genet-
icists, but for many of its early years it was synonymous
with the close partnership that Jim forged with Jack
Schull. For 20 years they were intellectual fellow trav-
elers who, among other contributions, helped found the
field of “genetic epidemiology” and largely introduced
the modern context of genetic approaches to complex
chronic disease (Neel and Schull 1954; Neel et al. 1965).
A mark of the times is that during that period they
regularly walked home together after work, providing
years of extensive, leisurely time to discuss the issues of
the day. Although it is easy to romanticize the past, in
its heyday the DHG displayed an intellectual depth that
elevated it above most of its peers and that represented
a living monument to its founder.
Research Legacy
Hemoglobinopathies
Jim’s first major contribution to human genetics in-
volved the inheritance of sickle-cell anemia. In our mo-
lecular age, it is difficult to appreciate how difficult it
was to discern the inheritance of these complex phe-
notypes, characterized by variable clinical severity in in-
dividuals of African descent. Using earlier insights from
his thalassemia studies, Jim solved the problem by de-
tailed analysis of phenotypic segregation. Controlling for
ascertainment in carefully identified families, he showed
that the sickle trait was the heterozygous condition—and
that sickle-cell disease was the recessive homozygous
condition—at a single Mendelian locus.
Shortly after Jim’s analysis, Linus Pauling’s group pre-
sented molecular confirmation of this conclusion. But
how could one account for the high frequency of this
deleterious condition in African Americans? Jim ap-
proached this problem as he did natural variation in
Drosophila. Ironically, he was to some extent thwarted
by his earlier success with Drosophila, since most of his
effort was spent examining evidence that a high recur-
rent mutation rate, or even admixture with Caucasian
genes, could be responsible for the apparently elevated
frequency of sickle-cell disease in North America com-
pared with that in Africa, despite his awareness of Beet’s
early observations about the differential rate of malarial
infection. Although Allison and Beet deserve credit for
recognizing the overdominant fitness of the sickle-cell
trait, without Jim’s groundwork this understanding
would have taken far longer to achieve.
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Mutation and Harmful Variation in the Human
Species: Japan
Just as he was starting his tour of duty in a U.S. Army
hospital, Lieutenant Neel was summoned to Washington
and was whisked onto a plane to Japan, to begin studies
of the effects of radiation exposure in survivors of the
atomic bombings. He had probably been identified for
this role through his mutation work with Stern and Spen-
cer. He arrived in 1946, just 15 months after the bomb-
ing, was a key person in the development of the scientific
program, and was asked to stay on as acting director
after his initial tour of duty. He thus played a leading
part in establishing the ABCC (now known as the “Ra-
diation Effects Research Foundation,” or RERF) in Hi-
roshima, and he continued working there for decades,
although from Michigan as his base.
Radiation dangers were paramount in the public mind
at the end of the war. Muller had shown that ionizing
radiation was mutagenic to the individual (e.g., see Mul-
ler 1947, 1950), and, for population geneticists, there
were additional grounds for concern. In the prevailing
theory of the time, mutation pressure was expected to
introduce only a small number of deleterious mutations.
These were predicted to be largely recessive (Fisher
1930), but, in small populations such as had character-
ized our ancestry, the high probability of homozygosity
would rapidly eliminate them. However, in the large,
heterogeneous outbred human populations of today,
with their diminished probability of homozygosity, a
mutational “load” of recessive mutations could accu-
mulate before the burden of their harmful homozygous
effects was borne (e.g., see Haldane 1937; Muller 1947).
The specter of nuclear weapons having been loosed
as a significant contributor to the mutation rate in hu-
mans, causing long-term damage to the gene pool,
“wonderfully concentrated” the public mind (Morton
1997). Even the survivors of nuclear holocaust would
bear a legacy of death for human posterity. It had been
difficult to quantify the radiation risk from therapeutic
or occupational exposures, because of the need for ex-
cessively large samples and longitudinal data. But such
data would be available in Japan, and the measurement
of the consequences of exposure became a high-visibility
endeavor, somewhat as is the urgent study of AIDS to-
day. The ABCC was probably the first nonmilitary me-
gascience biological project in history.
At the time there was no direct test for mutations (the
DNA era had not yet dawned). Instead, in a “model of
design and execution” (Morton 1997), the investigators
developed a set of surrogate criteria related to birth de-
fects and estimated the frequency of the various defects
in offspring born to survivors, in relation to dose (pub-
lished by Neel and Schull 1991). In a more recent and
direct attempt to estimate mutation rates in the exposed,
Jim helped lead a study of ∼500,000 tests, mainly of
protein polymorphisms, in each of two cohorts of ex-
posed and nonexposed individuals and their off-
spring—the largest such comparison that had been done
in humans. This involved his only real “genomics” ef-
fort, a collaborative effort to develop two-dimensional
electrophoretic polymorphism and mutation-detection
systems (Neel et al. 1984; Rosenblum et al. 1984).
Although the indicators were in the expected direc-
tion, the most striking result of this 40-years work was
that “in no instance is there a statistically significant
effect of parental exposure” (Schull et al. 1981, p. 1220).
Similarly inconclusive results were found in another clas-
sic mutation study, in which Jack and Jim used the com-
prehensive Japanese genealogical record–keeping system
to estimate the prevailing burden of recessive mutation,
on the basis of the excess frequency of defects expected
in offspring of inbred matings (Schull and Neel 1965,
1972; also see Morton et al. 1956; Morton 1997). Even
the huge sample sizes available were insufficient for char-
acterization of rare mutational events, especially with
indirect and incomplete detection technology.
Research on the effects of the atomic-bomb exposures
continues, but the question has changed in a biologically
interesting way. Over the postwar decades it was realized
that cancer was essentially a disease of somatic mutation.
Meanwhile, systematic lifelong increases in cancer risks
began to appear in the RERF cohorts decades after the
exposures (e.g., see Shimizu et al. 1990). One major
reason that the risk of cancer to exposed individuals is
much greater and more easily detected than that of ger-
minal mutation is that many more somatic than germinal
cells are exposed. Thus, if the feared threat to distant
human posterity is less than was thought, high doses of
radiation are a substantial threat for the duration of an
exposed person’s life.
Overall, an important inference from the inability to
detect a clear signal is that humans are less sensitive to
heritable radiation damage than they had been thought
to be (largely on the basis of a mouse model). Interest-
ingly, Jim had long acknowledged that, in this area of
great practical importance, the working assumptions are
so uncertain that a statistical significance level cannot
even be reliably placed on the results. This raises serious
and still-unanswered questions for determination of ra-
diation safety standards (Schull et al. 1981; Neel et al.
1990; Neel and Lewis 1990; Neel 1999)—even for can-
cer—especially at low or chronic doses.
It is worthwhile to note the caution with which these
expensive, highly visible studies were begun. A pro-
spectus published in Science clearly laid out the serious
sample-size limitations, even in the Hiroshima and Na-
gasaki material, in this study being led by a young Dr.
Neel. “Even after a long-term study, such as that outlined
below,” the report wrote, “it still may not be possible
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to determine just how much genetic damage was done
at Hiroshima and Nagasaki” (Genetics Conference
1947, p. 331). Nobody likes to spend his or her career
chasing a negative result, especially one clearly predicted
in his youth. Such candor would be death to any funding
opportunities today, but could anyone suggest that this
effort was a waste? Jim expressed a “twinge of envy”
(Neel 1994) for the more quick-hitting science that is
common today. But his twinge “didn’t last long. . . . If
one commits oneself to the field of human population
genetics, one must be prepared to pay the price” (Neel
1994, p. 246).
Mutations and Genetic Variation in Natural Human
Settings
Jim’s concern with the natural load of mutational ef-
fects—and his realization that human population history
was responsible for their amount and dispersion—led to
an interest in the study of humans in a more evolution-
arily natural state, where those processes could be ob-
served. He placed particular stress on the understanding
of local microdemographic events through which the
human evolutionary processes occurred.
Jim recognized that the cultural changes accompa-
nying the progression from tribal society to urbanization
had created novel environments for selection—and that
this contrast might reveal selective pressures, with
consequences for human health (Neel 1958b, 1966).
Reflecting this view was his “thrifty genotype” hypothe-
sis, suggesting that in modern society susceptibility to
diseases such as diabetes might be a deleterious con-
sequence of genotypes that had formerly been advan-
tageous in human ancestral environments (Neel
1962)—arguably one of the most influential hypotheses
in genetic epidemiology.
Jim soon put his view to the empirical test. He realized
that recently contacted tribes would be least affected by
traits of the outside civilization, such as diet and infec-
tious diseases. The Amazon basin was one of the best
available places in which to find such groups. Working
with South American colleagues, beginning in the 1960s,
he made an initial foray into the recently contacted
Xavante in the Brazilian Mato Groso. That provided
remarkable demographic and phenotypic data and
suggested unsuspected amounts of genetic difference be-
tween small, geographically adjacent villages. He then
turned his attention to the much larger tribal group, the
Yanomama, on the Brazilian-Venezuelan border. Over a
30-year period his work in a large number of Yanomama
villages and in at least 20 other tribes in South and
Central America generated a formidable set of data pro-
viding unparalleled and perhaps unrepeatable insight
into the evolutionary biology of our species (summarized
in Neel 1994).
Jim was directly involved in all phases of the opera-
tions, showing a natural flair for fieldwork under dif-
ficult conditions—including the need to spur on can-
tankerous, younger colleagues. A wide variety of poly-
morphisms have been defined, initially blood groups and
protein isozymes and continuing, today, to DNA-se-
quence variation. These data revealed a wholly unex-
pected magnitude of genetic variation in human popu-
lations, just when the merits of Kimura’s neutral theory
were being hotly debated. The many analyses of these
data have been influential in shaping our perception of
human genetic diversity, highlighting in particular the
role that sociocultural practices such as culturally de-
fined kinship relationships within and among local vil-
lages have in the shaping of human genetic diversity at
the micro scale (e.g., see Neel 1966, 1970). The contin-
ued existence of 15,000 or so samples collected 30 or
more years ago ensures that this scientific legacy will be
profitably mined for many years to come.
Jim and his colleagues also provided important phe-
notypic data from the Amazon. As he had predicted, the
forces of cultural change are eliminating the last vestiges
of “tribal physiology” at a much more rapid rate than
they are destroying the patterns of genetic variation. The
ecology of tribal societies gave rise to very different phys-
iological profiles and disease patterns: blood pressure
and glucose levels were radically lower than those in
contemporary urban populations, the distribution of in-
fectious disease was influenced by the same cultural fac-
tors that magnified genetic microdifferentiation, and the
detection of new pathogens, such as retroviral elements,
shed new light on infectious-disease ecology. There can
be little doubt that the selective pressures 10,000 years
ago were substantially different from those of the recent
past, a concept that has implications for how we design
studies of the genetic contribution to common disease.
A Few Personal Notes
Jim kept his private life private, and we will honor his
feelings—but will note that his was a life of high personal
standards. His professional interactions were insistent,
and he could be demanding. He was assertive within his
academic realm and highly competitive. We have nu-
merous times seen him hold his own in discussions with
persons of high technical skills, on issues within their
areas of expertise, by dint of personality and a pene-
trating ability to focus on the main issues. He could
intimidate the timid, and one had to defend one’s point
of view. But to those of us fortunate to be among his
students he gave considerable freedom of action. He
could, of course, also be compassionate and helpful, and
it is a mark of his character that he inspired a fierce
loyalty, especially among his staff. Although he spent
most of his academic life at one institution and trained
relatively few students, Jim had a profound impact on
the international scene. This was especially so in Japan
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and parts of Latin America, where, as a consequence of
his intense collaboration, he assisted the development of
a number of scientific groups. Nearly to the end of his
last year of life, he continued to foster the careers of
junior colleagues and students.
Conclusion
Except for the few and the lucky, leadership goes beyond
discoveries. Historians will trace the development of hu-
man genetics, now one of the most prominent of sci-
ences, to a few determined and dedicated people. Jim
Neel was a driving force among them. He was motivated
by intellectual rather than by material capital. Lists of
patents, citations, number of genes mapped will not tell
his story. His legacy is the emphasis that he placed on
the application of basic biological and evolutionary prin-
ciples to genetic variation in natural populations and to
the understanding of genetic etiology. This has shaped
our science in a manner probably not wholly appreciated
by those rushing pell-mell into biotechnology. Yet, with-
out Jim’s contributions, their opportunities might not
exist.
In his biography (Neel 1994), as a “physician to the
genome” Jim lays out his vision for the future of our
species. His views have received considerable attention.
When one of us (K.M.W.) was asked to review the
manuscript of this biography, he suggested to Jim that
the section be toned down, since it seemed to be an
elder statesman’s predictable petulance about the state
of the world. Characteristically, Jim refused. As we have
rediscovered, on rereading his papers while preparing
this tribute, he had been saying many of the same things
for at least 30 years, long before the current genomics
explosion. When placed in context they merit serious
examination.
Taking a natural historian’s perspective, Jim noted
the current belief that genetic knowledge will contribute
to public health by tailoring the genome to the envi-
ronment. He warned that this will be a wasteful and
probably losing proposition. As he repeatedly pointed
out, the essential facts have been known for a century
or more. Most of the complex multifactorial diseases
really are just that—complex, not “genetic” in the usual
sense. Their expression is heavily dependent on inter-
action with rapidly changing environments. Much more
effective and cost-efficient improvements to human
well-being can be made by tailoring the environment to
the genome. Lifestyle interventions are more practical
than genetic ones. Prevention, based on an understand-
ing of the nature of normal human genetic variation,
has the best chance of contributing to society. To un-
derstand the nature of genotype interactions, an evo-
lutionary perspective is required.
However, as Jim also warned, success in any such
strategy could lead to an increasingly aged society with
much greater health burdens. He suggests that we keep
our current love affair with mapping and cloning in
perspective. In particular, he warns that excessive con-
cern about genetic disease will become a trivial luxury
if we do not avoid the specter of global overpopulation
of the species to whose welfare he was so long dedicated
(Neel 1994, 1996, 1997).
Were these his salad days, Jim would be right at the
front of the technological edge (but with his yellow pad
and pencil), working on his next paper and badgering
some poor colleague to get his part done. But we think
that he would be arguing for a very different kind of
genome project. Instead of a preoccupation with disease
mining, he would be urging that effort be primarily
directed toward an understanding of the evolutionary
interactions within our naturally varying genome. Per-
haps, if we paid greater heed to these ideas of his, we
would advance the cause of genomics in a much more
useful and meaningful way.
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